Simon Francis Thomsen

Simon Francis Thomsen

Professor


  1. Published

    Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study

    Schwensen, J. F., Clemmensen, A., Sand, C., Gniadecki, R., Skov, Lone, Zachariae, Claus, Iversen, L., Rasmussen, M. & Thomsen, Simon Francis, Nov 2017, In: Dermatologic Therapy. 30, 6, 3 p., e12550.

    Research output: Contribution to journalLetterResearchpeer-review

  2. Published

    Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis

    Nielsen, V. W., Lund, T. T., Gniadecki, R., Olsen, Rasmus Huan, Nissen, C. V., Schwensen, J. F. B. & Thomsen, Simon Francis, 2020, In: Dermatologic Therapy. 33, 6, 2 p., e14258.

    Research output: Contribution to journalLetterResearchpeer-review

  3. Published

    Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis

    Lund, T., Sand, C., Gniadecki, R. & Thomsen, Simon Francis, 2019, In: Dermatologic Therapy. 32, 3, 2 p., e12846.

    Research output: Contribution to journalLetterResearchpeer-review

  4. Published

    Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study

    Yao, Y., Jorgensen, A. -. R., Ring, H. C. & Thomsen, Simon Francis, 2021, In: British Journal of Dermatology. 184, 3, p. 552-553 2 p.

    Research output: Contribution to journalLetterResearchpeer-review

  5. Published

    Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study

    Ghazanfar, M. N., Holm, J. G. & Thomsen, Simon Francis, Oct 2018, In: Journal of the European Academy of Dermatology and Venereology. Supplement. 32, 10, p. 1761-1767

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Effectiveness of phototherapy in chronic urticaria

    Thomsen, Simon Francis, Jan 2017, In: British Journal of Dermatology. 176, 1, 1 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  7. Published

    Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

    PEARL-1 and PEARL-2 trial investigators, P. A. P. T. I., 2024, In: Lancet (London, England). 403, 10422, p. 147-159 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)

    Gyldenløve, Mette, Meteran, H., Sørensen, J. A., Fage, S., Yao, Y., Lindhardsen, Jesper, Nissen, Christoffer Valdemar S, Todberg, T., Thomsen, Simon Francis, Skov, Lone, Zachariae, Claus, Iversen, L., Nielsen, M. & Egeberg, Alexander, 2023, In: The Lancet Regional Health - Europe. 30, 10 p., 100639.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Elderly male patients with hidradenitis suppurativa have more severe disease independent of disease duration

    Nielsen, V. W., Ring, H. C., Holgersen, N. & Thomsen, Simon Francis, 2024, In: British Journal of Dermatology. 190, 2, p. 292-293

    Research output: Contribution to journalLetterResearchpeer-review

  10. Published

    Elevating the Standard of Care for Patients with Psoriasis: ‘Calls to Action’ from Epicensus, a Multistakeholder Pan-European Initiative

    Koren, J., Lambert, J. L. W., Thomsen, Simon Francis, McAteer, H., Fabbrocini, G., Corazza, V., Jullien, D., Augustin, M., Warren, R. B., de Rie, M. A., Lazaridou, E., Puig, L., Guillevin, L., Grosser, M. & Boehncke, W. H., 2023, In: Dermatology and Therapy. 13, p. 245–268

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...8 9 10 11 12 13 14 15 ...31 Next

ID: 32452372